203 related articles for article (PubMed ID: 7500546)
1. Comparable effects of angiotensin II and converting enzyme blockade on hemodynamics and cardiac hypertrophy in spontaneously hypertensive rats.
Mori T; Nishimura H; Ueyama M; Kubota J; Kawamura K
Jpn Circ J; 1995 Sep; 59(9):624-30. PubMed ID: 7500546
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro.
Kojima M; Shiojima I; Yamazaki T; Komuro I; Zou Z; Wang Y; Mizuno T; Ueki K; Tobe K; Kadowaki T
Circulation; 1994 May; 89(5):2204-11. PubMed ID: 8181146
[TBL] [Abstract][Full Text] [Related]
3. Converting enzyme inhibition improves congestion and survival in hypertensive rats with high-output heart failure.
Nishimura H; Oka T; Ueyama M; Kubota J; Kawamura K
J Cardiovasc Pharmacol; 1994 Jan; 23(1):149-54. PubMed ID: 7511728
[TBL] [Abstract][Full Text] [Related]
4. Effect of an angiotensin II receptor antagonist, TCV-116, on cardiac hypertrophy and coronary circulation in spontaneously hypertensive rats.
Takeda K; Fujita H; Nakamura K; Uchida A; Tanaka M; Itoh H; Nakata T; Sasaki S; Nakagawa M
Blood Press Suppl; 1994; 5():94-8. PubMed ID: 7889211
[TBL] [Abstract][Full Text] [Related]
5. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
6. Effect of an angiotensin II receptor antagonist, TCV-116, on neointimal formation following balloon injury in the SHR carotid artery.
Kino H; Hama J; Takenaka T; Sugimura K; Kamoi K; Shimada S; Yamamoto Y; Nagata S; Kai T; Horiuchi M
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S360-2. PubMed ID: 9072428
[TBL] [Abstract][Full Text] [Related]
7. Regional hemodynamic effects of candesartan cilexetil (TCV-116), an angiotensin II AT1-receptor antagonist, in conscious spontaneously hypertensive rats.
Kanagawa R; Wada T; Sanada T; Ojima M; Inada Y
Jpn J Pharmacol; 1997 Mar; 73(3):185-90. PubMed ID: 9127812
[TBL] [Abstract][Full Text] [Related]
8. An angiotensin II receptor antagonist attenuates left ventricular dilatation after myocardial infarction in the hypertensive rat.
Nishikimi T; Yamagishi H; Takeuchi K; Takeda T
Cardiovasc Res; 1995 Jun; 29(6):856-61. PubMed ID: 7656290
[TBL] [Abstract][Full Text] [Related]
9. Advanced hypertensive heart disease in spontaneously hypertensive rats. Lisinopril-mediated regression of myocardial fibrosis.
Brilla CG; Matsubara L; Weber KT
Hypertension; 1996 Aug; 28(2):269-75. PubMed ID: 8707393
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
[TBL] [Abstract][Full Text] [Related]
11. TCV-116, a newly developed angiotensin II receptor antagonist, induces regression of cardiac hypertrophy through suppression of the tissue renin-angiotensin system in spontaneously hypertensive rats.
Mizuno K; Niimura S; Katoh K; Fukuchi S
Life Sci; 1994; 54(25):1987-94. PubMed ID: 8201847
[TBL] [Abstract][Full Text] [Related]
12. Effects of the non-peptide angiotensin II receptor antagonist TCV-116 on systemic and renal hemodynamics in dogs with renal hypertension.
Ito K; Shiomi M; Kito G
Hypertens Res; 1995 Mar; 18(1):69-75. PubMed ID: 7584913
[TBL] [Abstract][Full Text] [Related]
13. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Kohya T; Yokoshiki H; Tohse N; Kanno M; Nakaya H; Saito H; Kitabatake A
Circ Res; 1995 May; 76(5):892-9. PubMed ID: 7729007
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.
Ikeda Y; Nakamura T; Takano H; Kimura H; Obata JE; Takeda S; Hata A; Shido K; Mochizuki S; Yoshida Y
J Lab Clin Med; 2000 Apr; 135(4):353-9. PubMed ID: 10779052
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
Nakano N; Moriguchi A; Morishita R; Kida I; Tomita N; Matsumoto K; Nakamura T; Higaki J; Ogihara T
Hypertension; 1997 Dec; 30(6):1448-54. PubMed ID: 9403566
[TBL] [Abstract][Full Text] [Related]
16. Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR.
Tsuchihashi T; Kagiyama S; Matsumura K; Abe I; Fujishima M
J Hypertens; 1999 Jul; 17(7):917-22. PubMed ID: 10419064
[TBL] [Abstract][Full Text] [Related]
17. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy.
Brilla CG; Janicki JS; Weber KT
Circulation; 1991 May; 83(5):1771-9. PubMed ID: 1850668
[TBL] [Abstract][Full Text] [Related]
18. Renal responses to angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor in partially nephrectomized spontaneously hypertensive rats.
Okada H; Suzuki H; Kanno Y; Ikenaga H; Saruta T
J Cardiovasc Pharmacol; 1995 Oct; 26(4):564-9. PubMed ID: 8569216
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II type I receptor antagonist inhibits the gene expression of transforming growth factor-beta 1 and extracellular matrix in cardiac and vascular tissues of hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Ishimura Y; Chatani F; Iwao H
J Pharmacol Exp Ther; 1995 Apr; 273(1):509-15. PubMed ID: 7714806
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antihypertensive effects of the new angiotensin II (AT1) receptor antagonist candesartan cilexetil (TCV-116) and the angiotensin converting enzyme inhibitor enalapril in rats.
Wada T; Inada Y; Ojima M; Sanada T; Shibouta Y; Nishikawa K
Hypertens Res; 1996 Jun; 19(2):75-81. PubMed ID: 10968199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
